Injections bypass the digestive system, making them an effective option for these individuals
Bulletin of Experimental Biology and Medicine .PMID 14523518Read source (2020)
Headline results from a REDEFINE-2 late-stage trial released earlier this month showed that Novo's next-generation CagriSema helped obese or overweight adult patients with type 2 diabetes lose 15.7% of their weight over 68 weeks, compared with 3.1% with placebo
By restoring telomerase activity, Epithalon supports cellular replication, DNA integrity, and rejuvenation of aging cells
However, individual experiences may vary, so its advisable to discuss any concerns with your practitioner during your consultation
Some users report temporary fatigue or dizziness during the initial stages of treatment